This week, First Opinion authors explained why new regulations for prescribing controlled substances will create headaches for psychiatrists and patients alike, shared the lesson biotech should not take from the failure of Silicon Valley Bank, pleaded for clarity around how a new framework will affect living organ donors, and more. You can read all of the week's essays here. Please keep reading and sending ideas and essays to first.opinion@statnews.com.
No comments